These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25252702)

  • 1. Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: two case reports.
    Shiota T; Torimoto K; Momose H; Nakamuro T; Mochizuki H; Kumamoto H; Hirayama A; Fujimoto K
    BMC Res Notes; 2014 Sep; 7():672. PubMed ID: 25252702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
    Geller EJ; Crane AK; Wells EC; Robinson BL; Jannelli ML; Khandelwal CM; Connolly A; Parnell BA; Matthews CA; Dumond JB; Busby-Whitehead J
    Clin Drug Investig; 2012 Oct; 32(10):697-705. PubMed ID: 22873491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
    Rai BP; Cody JD; Alhasso A; Stewart L
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive burden and polypharmacy in elderly Japanese patients treated with anticholinergics for an overactive bladder.
    Shiota T; Torimoto K; Okuda M; Iwata R; Kumamoto H; Miyake M; Hirayama A; Tanaka N; Fujimoto K
    Low Urin Tract Symptoms; 2020 Jan; 12(1):54-61. PubMed ID: 31460706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of imidafenacin in female patients with urge and mixed urinary incontinence].
    Shimada M; Inoue K; Okumura T; Aoki S; Ogawa Y; Matsubara E; Maeda T; Ogawa Y; Sasaki H
    Hinyokika Kiyo; 2011 Jan; 57(1):1-6. PubMed ID: 21304252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatments for overactive bladder: focus on pharmacotherapy.
    Geoffrion R;
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidafenacin on bladder and cognitive function in neurologic OAB patients.
    Sakakibara R; Tateno F; Yano M; Takahashi O; Sugiyama M; Ogata T; Haruta H; Kishi M; Tsuyusaki Y; Yamamoto T; Uchiyama T; Yamanishi T; Yamaguchi C
    Clin Auton Res; 2013 Aug; 23(4):189-95. PubMed ID: 23820664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized, placebo-controlled, parallel study to evaluate the efficacy and safety of imidafenacin in patients with overactive bladder in Taiwan.
    Chuang YC; Lin CC; Chow PM; Lien CS; Tsui KH; Chou CL; Lee HY; Meng E; Kuo HC
    Low Urin Tract Symptoms; 2021 Jan; 13(1):108-117. PubMed ID: 32844599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB].
    Sakakibara R
    Rinsho Shinkeigaku; 2013; 53(11):1389-92. PubMed ID: 24292000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly].
    Kerdraon J; Robain G; Jeandel C; Mongiat Artus P; Gamé X; Fatton B; Scheiber-Nogueira MC; Vetel JM; Mares P; Petit AC; Amarenco G;
    Prog Urol; 2014 Sep; 24(11):672-81. PubMed ID: 25214448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults.
    Alhasso AA; McKinlay J; Patrick K; Stewart L
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003193. PubMed ID: 17054163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic burden in the Japanese elderly population: Use of antimuscarinic medications for overactive bladder patients.
    Yoshida M; Kato D; Nishimura T; Van Schyndle J; Uno S; Kimura T
    Int J Urol; 2018 Oct; 25(10):855-862. PubMed ID: 30069973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison].
    Goepel M; Schultz-Lampel D
    Urologe A; 2011 Jul; 50(7):802-5. PubMed ID: 21681456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
    Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which anticholinergic drug for overactive bladder symptoms in adults.
    Madhuvrata P; Cody JD; Ellis G; Herbison GP; Hay-Smith EJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005429. PubMed ID: 22258963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.
    Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):69-71. PubMed ID: 33497068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for the management of urgency symptoms in patients with overactive bladder syndrome.
    Cardozo LD; Van Kerrebroeck PE; Staskin DR
    World J Urol; 2009 Dec; 27(6):755-63. PubMed ID: 19690868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUGS Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.
    This document was developed by the American Urogynecologic Society (AUGS) Guidelines Committee with the assistance of Tonya N. Thomas, MD, and Mark D. Walters, MD. This document reflects clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Its content is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. The ultimate judgment regarding any specific procedure or treatment is to be made by the physician and patient in light of all circumstances presented by the patient.
    Female Pelvic Med Reconstr Surg; 2017; 23(3):177-178. PubMed ID: 28441276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing treatments for overactive bladder.
    Waine E; Stott M
    Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.